Yahya Çelik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yahya Çelik has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aksel Siva
Cerrahpasa School of Medicine, Istanbul University, Turkey
1 shared publication Asli Tuncer Kurne
Department of Neurology, Hacettepe University Medical School
1 shared publication- Ayse Altintas
Koc University, School of Medicine, Istanbul, Turkey
1 shared publication - Ayse Caylan
Trakya University Faculty of Medicine
1 shared publication - Aysun Soysal
Department of Neurology, Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital University of Health Sciences Istanbul Turkey
1 shared publication - Berna Balcı
Bahcesehir University
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43704
Association between circulating tryptophan metabolites and postoperative pain intensity in lumbar disc herniation surgery: An observational study
Gut microbiota is increasingly recognized for its involvement in pain modulation mechanisms, including visceral, inflammatory, neuropathic pain, and opioid tolerance. Although alterations in microbiota composition may affect host neuroimmune interactions, direct evidence in surgical pain contexts remains limited. This observational study explored associations between circulating tryptophan-derived metabolites and postoperative acute pain intensity in patients undergoing lumbar disc herniation surgery. Patients aged ≥ 18 years scheduled for lumbar disc herniation surgery were enrolled. Blood samples were obtained preoperatively and at 8 and 24 hours postoperatively to quantify tryptophan metabolites (picolinic acid, 3-OH kynurenine, anthranilic acid, kynurenine, quinolinic acid, kynurenic acid, and xanthurenic acid) via LC–MS/MS. Concurrent visual analog scale scores were recorded. Spearman correlation analysis was performed to evaluate associations between metabolite levels and pain scores. Thirty-seven patients (51.4% male, mean age 50.2 ± 11.8 years, body mass index 27.6 ± 2.9 kg/m2) were included. Significant perioperative changes were observed in picolinic acid (P = .001), kynurenic acid (P = .006), and xanthurenic acid (P < .001). Quinolinic acid levels correlated with 24-hour postoperative visual analog scale scores (r = 0.422; P = .009). Additional associations were identified between age and changes in picolinic acid (r = 0.357; P = .030), and between operation time and changes in 3-OH kynurenine (r = −0.359; P = .029). This exploratory analysis suggests that specific tryptophan metabolites, particularly quinolinic acid, may be linked to postoperative pain intensity and could serve as potential biomarkers in pain assessment. Future studies with direct microbiota profiling are needed to clarify the mechanistic pathways involved.
- 1 August 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (31) , e43704
Open AccessAssociation between circulating tryptophan metabolites and postoperative pain intensity in lumbar disc herniation surgery: An observational study
Gut microbiota is increasingly recognized for its involvement in pain modulation mechanisms, including visceral, inflammatory, neuropathic pain, and opioid tolerance. Although alterations in microbiota composition may affect host neuroimmune interactions, direct evidence in surgical pain contexts remains limited. This observational study explored associations between circulating tryptophan-derived metabolites and postoperative acute pain intensity in patients undergoing lumbar disc herniation surgery. Patients aged ≥ 18 years scheduled for lumbar disc herniation surgery were enrolled. Blood samples were obtained preoperatively and at 8 and 24 hours postoperatively to quantify tryptophan metabolites (picolinic acid, 3-OH kynurenine, anthranilic acid, kynurenine, quinolinic acid, kynurenic acid, and xanthurenic acid) via LC–MS/MS. Concurrent visual analog scale scores were recorded. Spearman correlation analysis was performed to evaluate associations between metabolite levels and pain scores. Thirty-seven patients (51.4% male, mean age 50.2 ± 11.8 years, body mass index 27.6 ± 2.9 kg/m2) were included. Significant perioperative changes were observed in picolinic acid (P = .001), kynurenic acid (P = .006), and xanthurenic acid (P < .001). Quinolinic acid levels correlated with 24-hour postoperative visual analog scale scores (r = 0.422; P = .009). Additional associations were identified between age and changes in picolinic acid (r = 0.357; P = .030), and between operation time and changes in 3-OH kynurenine (r = −0.359; P = .029). This exploratory analysis suggests that specific tryptophan metabolites, particularly quinolinic acid, may be linked to postoperative pain intensity and could serve as potential biomarkers in pain assessment. Future studies with direct microbiota profiling are needed to clarify the mechanistic pathways involved.
- 1 October 2015
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 20 (4) , 61-66
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort
Neuromyelitis optica (NMO) is an immune-mediated, chronic relapsing, inflammatory disease characterized by severe attacks of optic neuritis and myelitis. To determine the demographic, clinical, and laboratory features; antibody status; and treatment modalities of patients with NMO and neuromyelitis optica spectrum disorders in a Turkish cohort from 11 centers. A total of 182 patients were included in this study. Data on age at disease onset, sex, type of attacks, clinical presentation, analysis of cerebrospinal fluid, serum antiaquaporin-4 antibody status, annual progression index, and medical and family histories were collected. Mean age was 38.43±12.40 years (range, 13 to 75 y), and mean age at disease onset was 31.29±12.40 years (median, 29 y; range, 10 to 74 y). In NMO group, the rate of NMO immunoglobulin (Ig)G positivity was 62.5%. The annual progression index was significantly higher in the longitudinally extending spinal cord lesion. The mean Expanded Disability Status Scale score was higher in the late than early-onset NMO group. Our results revealed a lower rate of NMO IgG positivity, more severe disability in patients with NMO/neuromyelitis optica spectrum disorders presenting with either transverse myelitis or late-onset NMO, and no correlation between disability and NMO IgG status.
- 1 October 2015
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 20 (4) , 61-66
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort
Neuromyelitis optica (NMO) is an immune-mediated, chronic relapsing, inflammatory disease characterized by severe attacks of optic neuritis and myelitis. To determine the demographic, clinical, and laboratory features; antibody status; and treatment modalities of patients with NMO and neuromyelitis optica spectrum disorders in a Turkish cohort from 11 centers. A total of 182 patients were included in this study. Data on age at disease onset, sex, type of attacks, clinical presentation, analysis of cerebrospinal fluid, serum antiaquaporin-4 antibody status, annual progression index, and medical and family histories were collected. Mean age was 38.43±12.40 years (range, 13 to 75 y), and mean age at disease onset was 31.29±12.40 years (median, 29 y; range, 10 to 74 y). In NMO group, the rate of NMO immunoglobulin (Ig)G positivity was 62.5%. The annual progression index was significantly higher in the longitudinally extending spinal cord lesion. The mean Expanded Disability Status Scale score was higher in the late than early-onset NMO group. Our results revealed a lower rate of NMO IgG positivity, more severe disability in patients with NMO/neuromyelitis optica spectrum disorders presenting with either transverse myelitis or late-onset NMO, and no correlation between disability and NMO IgG status.
- 20 May 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (10) , 1805-1812
The prevalence of restless legs syndrome in Edirne and its districts concomitant comorbid conditions and secondary complications
We aimed to determine the prevalence and risk factors of restless legs syndrome in Edirne and its districts, located in Western Thrace, which is the most western part of Turkey. In this study, 4003 individuals who could communicate and agreed to participate in the study were evaluated. To obtain the data from the applicants in 30 Family Health Centres in Edirne and its districts, a face-to-face questionnaire that consisted of 54 questions was prepared by the researchers. The questionnaire included general information, questions to evaluate potential concomitant comorbid conditions and questions regarding the symptomatology used in restless legs syndrome (RLS) diagnosis, as well as questions to evaluate insomnia and tension-type headache secondary to insomnia according to the ICD-II Criteria (International Classification of Sleep Disorders-II Criteria). Of 4003 individuals, 282 were diagnosed with RLS according to the questionnaire results from Edirne and its districts, and the prevalence of RLS was 7 %. Approximately, 47.9 % of the patients with RLS were male, and 52.1 % were female, which was not significantly different (p > 0.05). Anaemia was identified in 41.1 % of the cases and control group was detected in 19.4 %, which was significantly different (p < 0.001). Secondary insomnia was identified in 64.2 % of the cases with RLS and was not detected in 35.8 %, which was significantly different (p < 0.001). RLS prevalence studies will increase the awareness of the community and provide early diagnosis and treatment, as well as serve as a basis to reduce morbidity and improve the quality of life.
- 20 May 2015
- Published by Springer Nature in Neurological Sciences
- Vol. 36 (10) , 1805-1812
The prevalence of restless legs syndrome in Edirne and its districts concomitant comorbid conditions and secondary complications
We aimed to determine the prevalence and risk factors of restless legs syndrome in Edirne and its districts, located in Western Thrace, which is the most western part of Turkey. In this study, 4003 individuals who could communicate and agreed to participate in the study were evaluated. To obtain the data from the applicants in 30 Family Health Centres in Edirne and its districts, a face-to-face questionnaire that consisted of 54 questions was prepared by the researchers. The questionnaire included general information, questions to evaluate potential concomitant comorbid conditions and questions regarding the symptomatology used in restless legs syndrome (RLS) diagnosis, as well as questions to evaluate insomnia and tension-type headache secondary to insomnia according to the ICD-II Criteria (International Classification of Sleep Disorders-II Criteria). Of 4003 individuals, 282 were diagnosed with RLS according to the questionnaire results from Edirne and its districts, and the prevalence of RLS was 7 %. Approximately, 47.9 % of the patients with RLS were male, and 52.1 % were female, which was not significantly different (p > 0.05). Anaemia was identified in 41.1 % of the cases and control group was detected in 19.4 %, which was significantly different (p < 0.001). Secondary insomnia was identified in 64.2 % of the cases with RLS and was not detected in 35.8 %, which was significantly different (p < 0.001). RLS prevalence studies will increase the awareness of the community and provide early diagnosis and treatment, as well as serve as a basis to reduce morbidity and improve the quality of life.
- 1 September 2001
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 10 (5) , 242-243
Bilaterally persistent horizontal gaze palsy and facial palsy caused by pontine infarction
- 1 September 2001
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 10 (5) , 242-243
Bilaterally persistent horizontal gaze palsy and facial palsy caused by pontine infarction